This inventor holds 1 USPTO granted patent. Top assignee: Pinotbio, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Young-Hwa Chun and Patent Activity in Biotechnology.
Introduction
Young-Hwa Chun is an inventor associated with Suwon, South Korea, and Pinotbio, Inc. The supplied information identifies her work in biotechnology and pharmaceutical research.
Latest Patents
Chun is credited with 1 patent: “Combined Therapy of 4'-Thio-5-Aza-2'-Deoxycytidine and Venetoclax.” The patent concerns a combination therapy involving the compounds named in its title.
Career Highlights
Chun’s listed patent activity connects her with Pinotbio, Inc., a company working in the biotechnology sector. The available information does not provide further details about her role or career history.
Collaborations
The supplied information lists Doo-Young Jung and Jin-Soo Lee as Chun’s coworkers. Their specific contributions to the patent are not provided.
Conclusion
Young-Hwa Chun’s recorded patent activity centers on a combination therapy involving 4'-thio-5-aza-2'-deoxycytidine and venetoclax, reflecting her association with biotechnology innovation at Pinotbio, Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile